[go: up one dir, main page]

HK1022918A1 - Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna - Google Patents

Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna Download PDF

Info

Publication number
HK1022918A1
HK1022918A1 HK00101819A HK00101819A HK1022918A1 HK 1022918 A1 HK1022918 A1 HK 1022918A1 HK 00101819 A HK00101819 A HK 00101819A HK 00101819 A HK00101819 A HK 00101819A HK 1022918 A1 HK1022918 A1 HK 1022918A1
Authority
HK
Hong Kong
Prior art keywords
tnfα
modified
molecule
sheet
seq
Prior art date
Application number
HK00101819A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1022918B (en
Inventor
M‧R‧詹森
S‧莫里生
H‧艾尔斯纳
I‧达鲁姆
Original Assignee
法默卡有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法默卡有限公司 filed Critical 法默卡有限公司
Publication of HK1022918A1 publication Critical patent/HK1022918A1/en
Publication of HK1022918B publication Critical patent/HK1022918B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/144Tumor necrosis factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00101819.7A 1997-04-15 1998-04-15 Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna HK1022918B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK41897 1997-04-15
DK0418/97 1997-04-15
US4418797P 1997-04-24 1997-04-24
US60/044,187 1997-04-24
PCT/DK1998/000157 WO1998046642A1 (en) 1997-04-15 1998-04-15 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA

Publications (2)

Publication Number Publication Date
HK1022918A1 true HK1022918A1 (en) 2000-08-25
HK1022918B HK1022918B (en) 2006-08-11

Family

ID=

Also Published As

Publication number Publication date
DE69834556D1 (de) 2006-06-22
ATE326481T1 (de) 2006-06-15
HRP980203A2 (en) 1998-12-31
AU743400B2 (en) 2002-01-24
US7118750B1 (en) 2006-10-10
HRP980203B1 (en) 2003-04-30
SI0975668T1 (sl) 2007-02-28
CA2289476A1 (en) 1998-10-22
WO1998046642A1 (en) 1998-10-22
KR20010006416A (ko) 2001-01-26
TR199902562T2 (xx) 2000-02-21
HUP0001930A3 (en) 2001-10-29
NO995002L (no) 1999-12-15
TW510921B (en) 2002-11-21
NZ337955A (en) 2000-09-29
CZ9903657A3 (cs) 2001-09-12
PL194221B1 (pl) 2007-05-31
SK140999A3 (en) 2000-06-12
JP2001521386A (ja) 2001-11-06
ZA983148B (en) 1999-10-15
DE69834556T2 (de) 2007-05-10
PL336295A1 (en) 2000-06-19
RU2241715C2 (ru) 2004-12-10
EP0975668A1 (en) 2000-02-02
UA72440C2 (en) 2005-03-15
CN1252809A (zh) 2000-05-10
EE9900461A (et) 2000-06-15
AR012427A1 (es) 2000-10-18
CN1178955C (zh) 2004-12-08
DK0975668T3 (da) 2006-09-25
KR100522289B1 (ko) 2005-10-19
IL132281A0 (en) 2001-03-19
ES2264569T3 (es) 2007-01-01
AU7030398A (en) 1998-11-11
BR9811462A (pt) 2000-09-12
HUP0001930A2 (hu) 2000-09-28
SK285639B6 (sk) 2007-05-03
EP0975668B1 (en) 2006-05-17
NO995002D0 (no) 1999-10-14

Similar Documents

Publication Publication Date Title
EP0975668B1 (en) MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA
US6645500B1 (en) Method for down-regulating osteoprotegerin ligand activity
JP2005518194A (ja) 乱交雑t細胞エピトープ挿入物を有するマルチマータンパク質の免疫原性擬態物
ZA200403686B (en) Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts
HK1022918B (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
AU2004235875A1 (en) Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
MXPA99009394A (es) Moleculas de tnfa modificadas, adn que modifica tales moleculas de tnfa modificadas y vacunas que comprenden tales moleculas tnfa modificadas y adn
CN101260152A (zh) 负调节Osteoprotegerin配体活性的方法
EP1541587A2 (en) Method for down-regulating osteoprotegerin ligand activity
AU2002342596A1 (en) Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100415